Index by author

September 01, 1987; Volume 15,Issue 5

A

  1. Alexander, D P

    1. Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;

B

  1. Babish, J G

    1. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;

  2. Bailie, M B

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  3. Balis, F M

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  4. Brady, J F

    1. Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;

  5. Broder, S

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

C

  1. Caldwell, J

    1. Criteria for the acceptability of experimental evidence for the enantiomeric composition of xenobiotics and their metabolites.
      J Caldwell and B Testa
      Drug Metabolism and Disposition September 1987, 15 (5) 587-588;

  2. Cary, P D

    1. The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;

  3. Cederbaum, A I

    1. Oxidation of the alcohol dehydrogenase inhibitor pyrazole to 4-hydroxypyrazole by microsomes. Effect of cytochrome P-450 inducing agents.
      D E Feierman and A I Cederbaum
      Drug Metabolism and Disposition September 1987, 15 (5) 634-639;

  4. Chen, L J

    1. Influence of gonadal hormones upon rat hepatic acetaminophen sulfotransferases.
      R F Kane and L J Chen
      Drug Metabolism and Disposition September 1987, 15 (5) 725-728;

  5. Cho, A K

    1. Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;

  6. Cho, D K

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  7. Combs, D

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  8. Cooney, D A

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

D

  1. Dekant, W

    1. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;

  2. Di Stefano, E W

    1. Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;

  3. Dokko, J

    1. Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
      J F Brady, J Dokko, E W Di Stefano and A K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 648-652;

  4. Dolce, K

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

F

  1. Farmer, P B

    1. The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;

  2. Federowicz, D A

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  3. Feierman, D E

    1. Oxidation of the alcohol dehydrogenase inhibitor pyrazole to 4-hydroxypyrazole by microsomes. Effect of cytochrome P-450 inducing agents.
      D E Feierman and A I Cederbaum
      Drug Metabolism and Disposition September 1987, 15 (5) 634-639;

  4. Feil, V J

    1. The disposition of N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide in the rat.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition September 1987, 15 (5) 671-675;

  5. Franklin, M R

    1. Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;

  6. Fullerton, F R

    1. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;

G

  1. Galinsky, R E

    1. Effect of cyclosporine on hepatic oxidative and conjugative metabolism in rats.
      R E Galinsky, D P Alexander and M R Franklin
      Drug Metabolism and Disposition September 1987, 15 (5) 731-733;

  2. Goodwin, R M

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;

  3. Gordon, W P

    1. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

  4. Greenman, D L

    1. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;

  5. Grover, P L

    1. The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;

  6. Guard, C L

    1. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;

H

  1. Hartman, N R

    1. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
      N R Hartman and I Jardine
      Drug Metabolism and Disposition September 1987, 15 (5) 661-664;

  2. Henschler, D

    1. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;

  3. Hoffmann, J S

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;

  4. Houston, J B

    1. Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.
      M Mistry and J B Houston
      Drug Metabolism and Disposition September 1987, 15 (5) 710-717;

  5. Huang, B L

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  6. Huitric, A C

    1. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

J

  1. James, M O

    1. In vivo and in vitro renal metabolism and excretion of benzoic acid by a marine teleost, the southern flounder.
      M O James and J B Pritchard
      Drug Metabolism and Disposition September 1987, 15 (5) 665-670;

  2. Jardine, I

    1. The in vitro activity, radioimmunoassay cross-reactivity, and molecular weight of thirteen rabbit cyclosporine metabolites.
      N R Hartman and I Jardine
      Drug Metabolism and Disposition September 1987, 15 (5) 661-664;

  3. Johns, D G

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  4. Jones, A D

    1. Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;

K

  1. Kahn, C

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  2. Kane, R F

    1. Influence of gonadal hormones upon rat hepatic acetaminophen sulfotransferases.
      R F Kane and L J Chen
      Drug Metabolism and Disposition September 1987, 15 (5) 725-728;

  3. Kau, D

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;

  4. Kelley, J A

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  5. Khalique, A

    1. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
      S M Somani and A Khalique
      Drug Metabolism and Disposition September 1987, 15 (5) 627-633;

L

  1. Landi, M S

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  2. Lee, F W

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  3. Litterst, C L

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

M

  1. Maddox, M L

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  2. Malet-Martino, M C

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;

  3. Martens, G

    1. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;

  4. Martino, R

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;

  5. McClanahan, R H

    1. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

  6. McKay, S

    1. The metabolism of 7-ethylbenz[a]anthracene by rat liver microsomal preparations.
      S McKay, P B Farmer, P D Cary and P L Grover
      Drug Metabolism and Disposition September 1987, 15 (5) 682-694;

  7. Metzler, M

    1. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;

  8. Mico, B A

    1. Pharmacokinetics of acetaminophen, vancomycin, and antipyrine in the Hanford miniature swine.
      M B Bailie, D A Federowicz, K Dolce, C Kahn, B A Mico and M S Landi
      Drug Metabolism and Disposition September 1987, 15 (5) 729-730;

  9. Mistry, M

    1. Glucuronidation in vitro and in vivo. Comparison of intestinal and hepatic conjugation of morphine, naloxone, and buprenorphine.
      M Mistry and J B Houston
      Drug Metabolism and Disposition September 1987, 15 (5) 710-717;

  10. Mroszczak, E J

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

N

  1. Nadkarni, M

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  2. Nelson, S D

    1. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

O

  1. Olson, J R

    1. Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      E S Shen and J R Olson
      Drug Metabolism and Disposition September 1987, 15 (5) 653-660;

P

  1. Paulson, G D

    1. The disposition of N-(4,6-dimethyl-2-pyrimidinyl)benzene[U-14C]sulfonamide in the rat.
      G D Paulson and V J Feil
      Drug Metabolism and Disposition September 1987, 15 (5) 671-675;

  2. Poplack, D G

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  3. Pris, J

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;

  4. Pritchard, J B

    1. In vivo and in vitro renal metabolism and excretion of benzoic acid by a marine teleost, the southern flounder.
      M O James and J B Pritchard
      Drug Metabolism and Disposition September 1987, 15 (5) 665-670;

R

  1. Roth, J S

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

  2. Russel, F G

    1. Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
      F G Russel, A C Wouterse and C A van Ginneken
      Drug Metabolism and Disposition September 1987, 15 (5) 695-701;

S

  1. Sarnquist, F H

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

  2. Schwark, W S

    1. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;

  3. Segall, H J

    1. Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;

  4. Seth, C L

    1. The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran.
      W P Gordon, A C Huitric, C L Seth, R H McClanahan and S D Nelson
      Drug Metabolism and Disposition September 1987, 15 (5) 589-594;

  5. Shen, E S

    1. Relationship between the murine Ah phenotype and the hepatic uptake and metabolism of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      E S Shen and J R Olson
      Drug Metabolism and Disposition September 1987, 15 (5) 653-660;

  6. Shoaf, S E

    1. The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.
      S E Shoaf, W S Schwark, C L Guard and J G Babish
      Drug Metabolism and Disposition September 1987, 15 (5) 676-681;

  7. Somani, S M

    1. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
      S M Somani and A Khalique
      Drug Metabolism and Disposition September 1987, 15 (5) 627-633;

  8. Spearman, M E

    1. Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys.
      M E Spearman, R M Goodwin and D Kau
      Drug Metabolism and Disposition September 1987, 15 (5) 640-647;

  9. Sultatos, L G

    1. The role of the liver in mediating the acute toxicity of the pesticide methyl parathion in the mouse.
      L G Sultatos
      Drug Metabolism and Disposition September 1987, 15 (5) 613-617;

T

  1. Testa, B

    1. Criteria for the acceptability of experimental evidence for the enantiomeric composition of xenobiotics and their metabolites.
      J Caldwell and B Testa
      Drug Metabolism and Disposition September 1987, 15 (5) 587-588;

  2. Tokes, L G

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

V

  1. Vamvakas, S

    1. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation.
      W Dekant, G Martens, S Vamvakas, M Metzler and D Henschler
      Drug Metabolism and Disposition September 1987, 15 (5) 702-709;

  2. Vialaneix, J P

    1. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance.
      J P Vialaneix, M C Malet-Martino, J S Hoffmann, J Pris and R Martino
      Drug Metabolism and Disposition September 1987, 15 (5) 718-724;

  3. Vistica, D T

    1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
      J A Kelley, C L Litterst, J S Roth, D T Vistica, D G Poplack, D A Cooney, M Nadkarni, F M Balis, S Broder and D G Johns
      Drug Metabolism and Disposition September 1987, 15 (5) 595-601;

W

  1. Winter, C K

    1. Distribution of trans-4-hydroxy-2-hexenal and tandem mass spectrometric detection of its urinary mercapturic acid in the rat.
      C K Winter, H J Segall and A D Jones
      Drug Metabolism and Disposition September 1987, 15 (5) 608-612;

  2. Wouterse, A C

    1. Physiologically based pharmacokinetic model for the renal clearance of salicyluric acid and the interaction with phenolsulfonphthalein in the dog.
      F G Russel, A C Wouterse and C A van Ginneken
      Drug Metabolism and Disposition September 1987, 15 (5) 695-701;

  3. Wu, A T

    1. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
      E J Mroszczak, F W Lee, D Combs, F H Sarnquist, B L Huang, A T Wu, L G Tokes, M L Maddox and D K Cho
      Drug Metabolism and Disposition September 1987, 15 (5) 618-626;

Y

  1. Young, J F

    1. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
      F R Fullerton, D L Greenman and J F Young
      Drug Metabolism and Disposition September 1987, 15 (5) 602-607;
Back to top

In this issue